Keywords: blonanserin; Dopamine supersensitivity; Dopamine D2 receptor; Dopamine D3 receptor; Locomotor activity; Haloperidol; Blonanserin;
مقالات ISI blonanserin (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: blonanserin; Isopropyl myristate; Drug-in-adhesive patch; Viscoelasticity; Drug release; Blonanserin;
Keywords: blonanserin; BPRS; Brief Psychiatric Rating Scale; CGI-S; Clinical Global Impression-Severity of Illness; CP; chlorpromazine-equivalent doses of antipsychotics; DRD2; dopamine D2 receptors; DSP; dopamine supersensitivity psychosis; GAF; Global Assessment of Functionin
Keywords: blonanserin; Antipsychotic agents; Blonanserin; Randomized controlled trial; Risperidone; Schizophrenia;
Effects of clozapine on adipokine secretions/productions and lipid droplets in 3T3-L1 adipocytes
Keywords: blonanserin; Clozapine; Blonanserin; Leptin; 3T3-L1 adipocyte; Metabolic syndrome;
The atypical antipsychotic blonanserin reverses (+)-PD-128907- and ketamine-induced deficit in executive function in common marmosets
Keywords: blonanserin; Common marmoset; Schizophrenia; Object retrieval with detour (ORD) task; Blonanserin; Dopamine D3 receptor; Ketamine
Atypical antipsychotic properties of AD-6048, a primary metabolite of blonanserin
Keywords: blonanserin; EPS; Extrapyramidal side effects; HAL; Haloperidol; APO; Apomorphine; AcS; Shell part of nucleus accumbens; dlST; Dorsolateral striatum; MED; Minimum effective dose; Atypical antipsychotic; Blonanserin; AD-6048; Antipsychotic actions; Extrapyramidal side
Comprehensive DNA methylation analysis of human neuroblastoma cells treated with blonanserin
Keywords: blonanserin; DRD2; dopamine receptor 2; GWAS; genome-wide association study; HDAC2; histone deacetylase 2; HTR2A; serotonin receptor 2A; mGluR2; metabotropic glutamate receptor 2; PCA; principle component analysis; Blonanserin; DNA methylation; Human neuroblastoma cel
La théorie du néo-organodynamisme : une nouvelle classification pratique des maladies mentales
Keywords: blonanserin; Blonansérine; Classification des maladies mentales; Néo-organodynamisme; Organodynamisme; Voie accessoireAccessory pathway; Blonanserin; Classification of mental illness; Neo-organodynamism; Organodynamism
Blonanserin for schizophrenia: Systematic review and meta-analysis of double-blind, randomized, controlled trials
Keywords: blonanserin; Schizophrenia; Antipsychotic; Blonanserin; Risperidone; Haloperidol; Meta-analysis; Systematic review;
Effect of blonanserin on methamphetamine-induced disruption of latent inhibition and c-Fos expression in rats
Keywords: blonanserin; Blonanserin; Haloperidol; Latent inhibition; Immediate-early gene protein; Schizophrenia;
Blonanserin reverses the phencyclidine (PCP)-induced impairment in novel object recognition (NOR) in rats: Role of indirect 5-HT1A partial agonism
Keywords: blonanserin; Phencyclidine; Novel object recognition; Schizophrenia; 5-HT1A; Blonanserin; CognitionAch, acetylcholine; ANOVA, analysis of variance; APD, antipsychotic drugs; CIS, cognitive impairment in schizophrenia; DA, dopamine; DI, discrimination index; EPS, extra
Simultaneous determination of blonanserin and its four metabolites in human plasma using ultra-performance liquid chromatography–tandem mass spectrometry
Keywords: blonanserin; Determination; Blonanserin; Metabolite; UPLC–MS/MS; Human plasma
Blonanserin, a novel atypical antipsychotic agent not actively transported as substrate by P-glycoprotein
Keywords: blonanserin; AUC0-6Â h; Area under the plasma concentration time curve from 0 to 6Â h; B/P; Brain/Plasma; BSA; Bovine serum albumin; Cmax; Maximum drug concentration; CNS; Central nervous system; DDI; Drug-drug interaction; EPS; Extrapyramidal symptoms; FBS; Fetal
Simultaneous determination of blonanserin and its metabolite in human plasma and urine by liquid chromatography–tandem mass spectrometry: Application to a pharmacokinetic study
Keywords: blonanserin; Blonanserin; Metabolite; HPLC–MS/MS; Human plasma; Pharmacokinetics
Behavioural PharmacologyEffect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex
Keywords: blonanserin; Blonanserin; Antipsychotic; Microdialysis; Schizophrenia; Norepinephrine; Dopamine; Serotonin; GABA; Glutamate;
Atypical antipsychotic properties of blonanserin, a novel dopamine D2 and 5-HT2A antagonist
Keywords: blonanserin; Antipsychotics; Blonanserin; Extrapyramidal side effects; Fos expression; Nucleus accumbens; Striatum
Syntheses and properties of the major hydroxy metabolites in humans of blonanserin AD-5423, a novel antipsychotic agent
Keywords: blonanserin; Blonanserin; AD-5423; Hydroxyl metabolites; Antipsychotic agent;